Are there differences in the treatment strategies and outcomes between high-risk multiple myeloma patients and those with low-risk disease and without comorbities?. Hematol Meeting Rep [Internet]. 2009 Jun. 8 [cited 2025 Jun. 20];2(7). Available from: https://journals.pagepress.org/hmr/article/view/407